Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxing Tantai

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Hepatology (Baltimore, Md.)|January 7, 2020
Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver DiseaseXinxing Tantai, Na Liu, Jinhai Wang
Hepatology (Baltimore, Md.)|April 8, 2025
Letter to the Editor: Post-TIPS hemodynamic target adherence fails to improve outcomes in cirrhotic patientsXinxing Tantai, Lu Li, Shejiao Dai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Considerations on TIPS Stent Diameter Selection in Patients With Cirrhosis at Risk of Hepatic EncephalopathyXinxing Tantai, Lu Li, Shejiao Dai
Hepatology (Baltimore, Md.)|April 5, 2023
Letter to the editor: Targeted decrease of portal hepatic pressure gradient immediately after TIPS improves ascites control and prognosisXinxing Tantai, Jinhai Wang, Shejiao Dai
Hepatology (Baltimore, Md.)|April 8, 2025
Letter to the Editor: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopeniaXinxing Tantai, Lu Li, Shejiao Dai
Purinergic Signalling|November 16, 2024
Antagonism of the ATP-gated P2X7 receptor inhibits the proliferation of hepatocellular carcinoma cellsXinxing Tantai, Xin Yang, Xinyuan Liu, et al.
Journal of Hepatology|March 30, 2022
Reply to: "Gut liver muscle brain axis: A comprehensive viewpoint on prognosis in cirrhosis"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Journal of Hepatology|May 3, 2022
Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Hepatobiliary Surgery and Nutrition|June 24, 2024
Reassessing the impact of post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy on mortality in patients with cirrhosisQiuju Ran, Zhang Wen, Shuyue Tuo, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2024
Reply - Letter to the editor "The egg and the chicken: Does sarcopenia or cognitive impairment come first?"Shuyue Tuo, Zhang Wen, Qiuju Ran, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Hepatology (Baltimore, Md.)|January 7, 2020
Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver DiseaseXinxing Tantai, Na Liu, Jinhai Wang
Hepatology (Baltimore, Md.)|April 8, 2025
Letter to the Editor: Post-TIPS hemodynamic target adherence fails to improve outcomes in cirrhotic patientsXinxing Tantai, Lu Li, Shejiao Dai
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2025
Considerations on TIPS Stent Diameter Selection in Patients With Cirrhosis at Risk of Hepatic EncephalopathyXinxing Tantai, Lu Li, Shejiao Dai
Hepatology (Baltimore, Md.)|April 5, 2023
Letter to the editor: Targeted decrease of portal hepatic pressure gradient immediately after TIPS improves ascites control and prognosisXinxing Tantai, Jinhai Wang, Shejiao Dai
Hepatology (Baltimore, Md.)|April 8, 2025
Letter to the Editor: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopeniaXinxing Tantai, Lu Li, Shejiao Dai
Purinergic Signalling|November 16, 2024
Antagonism of the ATP-gated P2X7 receptor inhibits the proliferation of hepatocellular carcinoma cellsXinxing Tantai, Xin Yang, Xinyuan Liu, et al.
Journal of Hepatology|March 30, 2022
Reply to: "Gut liver muscle brain axis: A comprehensive viewpoint on prognosis in cirrhosis"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Journal of Hepatology|May 3, 2022
Reply to: "Evaluating sarcopenia in patients with cirrhosis: The role of muscle function"Xinxing Tantai, Yee Hui Yeo, Jinhai Wang, et al.
Hepatobiliary Surgery and Nutrition|June 24, 2024
Reassessing the impact of post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy on mortality in patients with cirrhosisQiuju Ran, Zhang Wen, Shuyue Tuo, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 1, 2024
Reply - Letter to the editor "The egg and the chicken: Does sarcopenia or cognitive impairment come first?"Shuyue Tuo, Zhang Wen, Qiuju Ran, et al.
Pageof 3